Peptide Receptor Radionuclide Therapy Market
Peptidrezeptor-Radionuklidtherapie PRRT-Marktforschungsbericht nach Indikation (neuroendokrine Tumoren, Prostatakrebs, Phäochromozytom, Magenkarzinoidtumoren), nach Art der Therapie (therapeutische Radiopharmazeutika, diagnostische Radiopharmazeutika, Kombinationstherapie), nach Verabreichungsweg (intravenös, subkutan), nach Endbenutzer (Krankenhäuser, Spezialkliniken, Forschungsinstitute) und nach Regionen (Nordamerika, Europa, Südamerika, Asien-Pazifik, Naher Osten und Afrika) – Prognose bis 2034
Zu den wichtigsten Unternehmen im Peptide Receptor Radionuclide Therapy Market-Markt gehören
Berichtsumfang
FAQs
What is the current market valuation of the Peptide Receptor Radionuclide Therapy (PRRT) market?
The Peptide Receptor Radionuclide Therapy market was valued at 2.848 USD Billion in 2024.
What is the projected market size for PRRT by 2035?
The market is expected to reach 7.335 USD Billion by 2035.
What is the expected CAGR for the PRRT market during the forecast period 2025 - 2035?
The expected CAGR for the PRRT market during 2025 - 2035 is 8.98%.
Which companies are the key players in the PRRT market?
Key players in the PRRT market include Novartis, Bayer, Ipsen, Advanced Accelerator Applications, Lantheus Medical Imaging, TheraP, Siemens Healthineers, and GE Healthcare.
What are the primary indications for PRRT?
The primary indications for PRRT include Neuroendocrine Tumors, Prostate Cancer, Pheochromocytoma, and Gastric Carcinoid Tumors.
How is the PRRT market segmented by type of therapy?
The PRRT market is segmented into Therapeutic Radiopharmaceuticals, Diagnostic Radiopharmaceuticals, and Combination Therapy.
What are the projected revenues for Neuroendocrine Tumors in the PRRT market by 2035?
Revenues for Neuroendocrine Tumors are projected to reach 3.675 USD Billion by 2035.
What is the expected revenue for hospitals as end users of PRRT by 2035?
Hospitals are expected to generate revenues of 3.675 USD Billion as end users of PRRT by 2035.
What administration routes are utilized in the PRRT market?
The PRRT market utilizes both Intravenous and Subcutaneous administration routes.
How does the revenue for specialized clinics compare to hospitals in the PRRT market by 2035?
By 2035, specialized clinics are projected to generate 2.215 USD Billion, which is significantly lower than the 3.675 USD Billion expected for hospitals.
Bitte füllen Sie das folgende Formular aus, um ein kostenloses Muster dieses Berichts zu erhalten
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
“Thank you, this will be very helpful for OQS.”
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Einen Kommentar hinterlassen